The role of trained immunity in chronic non-communicable inflammatory diseases
Innate Immunity · 2026-04 · 32
DOI: 10.1177/17534259261446050 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Innate Immunity, online erschienen am 22.04.2026. Verfasst von Joseph Mucumbitsi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Adventist University of Central Africa (AUCA), Adventist School of Medicine of East Central Africa (ASOME), Kigali, Rwand…. Hauptthemen laut MEDLINE: Chronic Disease, Inflammation, Trained Immunity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Trained immunity, a form of long-term functional reprogramming of innate immune cells through epigenetic and metabolic changes, traditionally confers protection against infections. However, inappropriate activation by endogenous sterile stimuli can drive persistent maladaptive inflammation in non-communicable diseases (NCDs).
Objective
This systematic review synthesizes primary evidence for trained immunity in atherosclerosis, type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and neurodegenerative disorders, focusing on endogenous inducers, cellular mediators, mechanisms, and translational implications. Data Sources and Methods Following PRISMA guidelines, we included original studies demonstrating trained immunity induced by sterile endogenous signals in the targeted diseases. Narrative synthesis was performed due to heterogeneity precluding meta-analysis.
Results
Twelve primary studies met the inclusion criteria. In atherosclerosis (n = 8 studies), oxLDL, aldosterone, Western diet lipids, and post-myocardial infarction signals induced trained immunity in monocytes or macrophages and hematopoietic progenitors via H3K4me3 enrichment, mTOR/NLRP3 activation, and glycolytic/fatty acid shifts, leading to persistent cytokine hyperproduction (TNF-α, IL-6), foam cell formation, and transmissible plaque progression. In T2DM/hyperglycemia (n = 3), high glucose levels triggered MLL-mediated epigenetic reprogramming and glycolysis-dependent “metabolic memory,” which skewed myelopoiesis and accelerated atherosclerosis despite normoglycemia. In CKD (n = 1), indoxyl sulfate induced AhR-dependent arachidonic acid pathway activation with metabolic rewiring, sustaining systemic inflammation. In neurodegeneration (n = 1), peripheral stimuli caused epigenetic reprogramming in microglia, yielding hyperresponsive or tolerized states modulating amyloid-β pathology. Convergent mechanisms (H3K4me3, glycolysis, mTOR/AhR/NLRP3) highlight trained immunity as a shared driver of chronic sterile inflammation.
Conclusions
Trained immunity emerges as a unifying maladaptive mechanism perpetuating low-grade inflammation across these diseases, bridging transient endogenous insults to sustained pathology. Targeting reprogramming pathways, such as glycolysis or epigenetic inhibitors, offers promising therapeutic strategies. Expanded human studies are needed to address preclinical dominance and data gaps, particularly in CKD and neurodegeneration, where evidence is preliminary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Adventist University of Central Africa (AUCA), Adventist School of Medicine of East Central Africa (ASOME), Kigali, Rwanda.
- Department of Physiology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda.
- Department of Biochemistry, Adventist University of Central Africa (AUCA), Adventist School of Medicine of East Central Africa (ASOME), Kigali, Rwanda.
- Department of Intensive Care Unit, University Teaching Hospital of Kigali (CHUK), Kigali, Rwanda.
- Vice Dean, Adventist School of Medicine of East-Central Africa (ASOME), Kigali, Rwanda.
- Associate Dean of Medical Education, Adventist School of Medicine of East-Central Africa (ASOME), Kigali, Rwanda.
ORCID-Profile: Abdullateef Isiaka Alagbonsi
Zitieren
APA
Mucumbitsi, J., Hakizimana, J. C., Kampire, M. G., Kaneza, C., Bushobozi, T., Mukantwari, S., Ngaboyishema, J. M., Butera, A., & Alagbonsi, A. I. (2026). The role of trained immunity in chronic non-communicable inflammatory diseases. Innate Immunity, 32. https://doi.org/10.1177/17534259261446050
Vancouver
Mucumbitsi J, Hakizimana JC, Kampire MG, Kaneza C, Bushobozi T, Mukantwari S, et al. The role of trained immunity in chronic non-communicable inflammatory diseases. Innate Immunity. 2026;32. doi:10.1177/17534259261446050
BibTeX
@article{Mucumbitsi2026,
author = {Mucumbitsi, Joseph and Hakizimana, Jean Claude and Kampire, Marie Gorette and Kaneza, Callixta and Bushobozi, Themistocles and Mukantwari, Sophie and Ngaboyishema, Jean Mfizi and Butera, Alex and Alagbonsi, Abdullateef Isiaka},
title = {The role of trained immunity in chronic non-communicable inflammatory diseases},
journal = {Innate Immunity},
year = {2026},
volume = {32},
doi = {10.1177/17534259261446050}
}
EUVIMED